Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
ADI
|
Katsufumi Nakamura
SVP, Chief Customer Officer |
SELL
Open market or private sale
|
Direct | 500 Reduced 3.65% |
$144,585
$289.17 p/Share
|
Jan 07
2026 |
|
DLHC
|
Mink Brook Asset Management LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 3,569 Added 0.0% |
$19,629
$5.5 p/Share
|
Jan 07
2026 |
|
MNTR
|
Chester Billingsley
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 2,000 Added 0.06% |
$180
$0.09 p/Share
|
Jan 07
2026 |
|
SEMR
|
Dmitry Melnikov
Director |
SELL
Open market or private sale
|
Direct | 1,399 Reduced 0.07% |
$16,648
$11.9 p/Share
|
Jan 07
2026 |
|
ANAB
|
Daniel Faga
President, CEO |
SELL
Open market or private sale
|
Direct | 9,202 Reduced 1.93% |
$415,102
$45.11 p/Share
|
Jan 07
2026 |
|
ANAB
|
Paul F. Lizzul
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 2,235 Reduced 5.67% |
$100,820
$45.11 p/Share
|
Jan 07
2026 |
|
ANAB
|
Eric J Loumeau
CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct | 9,639 Reduced 51.28% |
$443,008
$45.96 p/Share
|
Jan 07
2026 |
|
TEAM
|
Michael Cannon Brookes
CEO, Co-Founder |
SELL
Open market or private sale
|
Indirect | 7,665 Reduced 0.0% |
$1,233,605
$160.94 p/Share
|
Jan 07
2026 |
|
ANAB
|
Dennis Mulroy
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 1,908 Reduced 9.75% |
$86,069
$45.11 p/Share
|
Jan 07
2026 |
|
LLY
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct | 292,148 Reduced 0.32% |
$321,803,943
$1101.51 p/Share
|
Jan 07
2026 |
|
REGN
|
Bonnie L Bassler
Director |
SELL
Open market or private sale
|
Direct | 1,500 Reduced 46.83% |
$1,200,000
$800.0 p/Share
|
Jan 07
2026 |
|
INCY
|
Mohamed Khairie Issa
EVP, Head of US Oncology |
SELL
Open market or private sale
|
Direct | 10,856 Reduced 14.1% |
$1,184,063
$109.07 p/Share
|
Jan 07
2026 |
|
TEAM
|
Scott Farquhar |
SELL
Open market or private sale
|
Indirect | 7,665 Reduced 0.0% |
$1,233,605
$160.94 p/Share
|
Jan 07
2026 |
|
RSMDF
|
Michael J. Farrell
Chairman and CEO |
SELL
Open market or private sale
|
Direct | 4,991 Reduced 1.06% |
$1,240,063
$248.46 p/Share
|
Jan 07
2026 |
|
CSAI
|
Sheldon Richard Bentley
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 33.33% |
$21,250
$0.85 p/Share
|
Jan 07
2026 |
|
PLNHF
|
Chris Wren
VP of Operations |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 0.76% |
$6,000
$0.2 p/Share
|
Jan 07
2026 |
|
IIF
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 3,359 Reduced 0.0% |
$84,142
$25.05 p/Share
|
Jan 07
2026 |
|
GF
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 2,752 Added 0.0% |
$32,913
$11.96 p/Share
|
Jan 07
2026 |
|
COSM
|
Grigorios Siokas
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 124,880 Added 1.76% |
$64,937
$0.52 p/Share
|
Jan 07
2026 |
|
ASA
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 3,598 Added 0.0% |
$215,088
$59.78 p/Share
|
Jan 07
2026 |
|
MEGI
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 47,547 Reduced 0.0% |
$651,393
$13.7 p/Share
|
Jan 07
2026 |
|
KEQU
|
Thomas David Hull Iii
President, CEO |
SELL
Open market or private sale
|
Direct | 2,177 Reduced 6.19% |
$81,637
$37.5 p/Share
|
Jan 07
2026 |
|
LUCY
|
Vladimir Galkin |
SELL
Open market or private purchase
|
Direct | 643,505 Reduced 100.0% |
$1,151,873
$1.79 p/Share
|
Jan 07
2026 |
|
ABOS
|
Russell Barton
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 1,700 Reduced 1.32% |
$3,383
$1.99 p/Share
|
Jan 07
2026 |
|
ABOS
|
Derek M Meisner
Chief Legal Officer & Corp Sec |
SELL
Open market or private sale
|
Direct | 11,770 Reduced 8.05% |
$23,422
$1.99 p/Share
|
Jan 07
2026 |
|
ABOS
|
Daniel Joseph O Connell
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 37,755 Reduced 5.74% |
$75,132
$1.99 p/Share
|
Jan 07
2026 |
|
ABOS
|
Matt Zuga
CFO & Chief Business Officer |
SELL
Open market or private sale
|
Direct | 5,805 Reduced 2.61% |
$11,610
$2.0 p/Share
|
Jan 07
2026 |
|
CCB
|
Eric M Sprink
CEO |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 1.61% |
$352,800
$117.6 p/Share
|
Jan 07
2026 |
|
PPTA
|
Alexander Mc Leod Sternhell
Director |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 15.5% |
$87,270
$29.09 p/Share
|
Jan 07
2026 |
|
WRB
|
Mitsui Sumitomo Insurance CO LTD |
BUY
Open market or private purchase
|
Direct | 265,000 Added 0.51% |
$18,239,950
$68.83 p/Share
|
Jan 07
2026 |
|
NTSK
|
Sanjay Beri
CEO and Chairman |
SELL
Open market or private sale
|
Direct | 31,594 Reduced 100.0% |
$555,422
$17.58 p/Share
|
Jan 07
2026 |
|
AXSM
|
Herriot Tabuteau
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 31,261 Reduced 81.22% |
$5,326,249
$170.38 p/Share
|
Jan 07
2026 |
|
MUSA
|
Malynda K West
President & CEO |
SELL
Open market or private sale
|
Direct | 4,051 Reduced 3.34% |
$1,721,675
$425.0 p/Share
|
Jan 07
2026 |
|
GSAT
|
Paul E Jacobs
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 845 Reduced 1.42% |
$55,601
$65.8 p/Share
|
Jan 07
2026 |
|
PMCB
|
Jonathan Schechter
Director |
BUY
Open market or private purchase
|
Direct | 20,000 Added 9.41% |
$16,800
$0.84 p/Share
|
Jan 07
2026 |
|
PMCB
|
Joshua Silverman
CEO and President |
BUY
Open market or private purchase
|
Direct | 40,000 Added 8.77% |
$33,200
$0.83 p/Share
|
Jan 07
2026 |
|
CLNN
|
Chidozie Ugwumba
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 3,938 Reduced 0.0% |
$24,770
$6.29 p/Share
|
Jan 07
2026 |
|
CLOV
|
Jamie L. Reynoso
CEO, Medicare Advantage |
SELL
Open market or private sale
|
Direct | 2,102 Reduced 0.08% |
$5,318
$2.53 p/Share
|
Jan 07
2026 |
|
HOWL
|
Luke Evnin |
SELL
Open market or private sale
|
Indirect | 11,915 Reduced 0.0% |
$7,625
$0.64 p/Share
|
Jan 07
2026 |
|
HGTY
|
Kenneth Ahn
President, Hagerty Marketplace |
SELL
Open market or private sale
|
Indirect | 24,247 Reduced 0.0% |
$317,150
$13.08 p/Share
|
Jan 07
2026 |
|
ACN
|
Mauro Macchi
Chief Executive Officer-EMEA |
SELL
Open market or private sale
|
Direct | 500 Reduced 6.16% |
$140,000
$280.0 p/Share
|
Jan 07
2026 |
|
UWMC
|
Ishbia Mat
President and CEO |
SELL
Open market or private sale
|
Indirect | 632,874 Reduced 0.0% |
$2,974,507
$4.7 p/Share
|
Jan 07
2026 |
|
GLPI
|
Steven Ladany
SVP Chief Development Officer |
SELL
Open market or private sale
|
Direct | 13,409 Reduced 18.81% |
$603,941
$45.04 p/Share
|
Jan 07
2026 |
|
CRCT
|
Arora Ashish
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 20,833 Reduced 0.5% |
$102,706
$4.93 p/Share
|
Jan 07
2026 |
|
PATH
|
Daniel Dines
CEO and Chairman |
SELL
Open market or private sale
|
Direct | 45,000 Reduced 0.16% |
$779,400
$17.32 p/Share
|
Jan 07
2026 |
|
PB
|
Ned S Holmes |
SELL
Open market or private sale
|
Indirect | 600 Reduced 0.0% |
$41,988
$69.98 p/Share
|
Jan 07
2026 |
|
PB
|
Ned S Holmes |
SELL
Open market or private sale
|
Direct | 500 Reduced 0.59% |
$34,985
$69.97 p/Share
|
Jan 07
2026 |
|
VIRC
|
Bradley C Richardson
Director |
BUY
Open market or private purchase
|
Direct | 2,000 Added 5.03% |
$13,000
$6.5 p/Share
|
Jan 07
2026 |
|
MAX
|
Eugene Nonko
Director |
SELL
Open market or private sale
|
Direct | 5,400 Reduced 0.54% |
$63,018
$11.67 p/Share
|
Jan 07
2026 |
|
MAX
|
Eugene Nonko
Director |
SELL
Open market or private sale
|
Indirect | 6,700 Reduced 0.0% |
$78,122
$11.66 p/Share
|
Jan 07
2026 |